摘要
T cells play a basic and key role in immunotherapy against solid tumors, and efficiently recruiting them into neoplastic foci and sustaining long-term effector function are consistent goals that remain a critical challenge. Here, an injectable alginate-based hydrogel with abundant beta-cyclodextrin (ALG-beta CD) sites is developed and intratumorally injected to recruit CCR9(+)CD8(+ )T cells (a subset of T cells with robust antitumor activity) via the trapped chemokine CCL25. In the meantime, an intravenously injected adamantane-decorated anti-PD1 antibody (Ad-aPD1) would hitchhike on recruited CCR9(+)CD8(+) T cells to achieve the improved intratumoral accumulation of Ad-aPD1. Moreover, the Ad-PD1 and Ad-PDL1 antibodies are immobilized in the ALG-beta CD hydrogel through supramolecular host-guest interactions of Ad and beta CD, which facilitate engagement between CD8(+) T cells and tumor cells and reinvigorate CD8(+) T cells to avoid exhaustion. Based on this treatment strategy, T cell-mediated anticancer activity is promoted at multiple levels, eventually achieving superior antitumor efficacy in both orthotopic and postsurgical B16-F10 tumor models.
学科与关键词
- Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor MicroenvironmentLiu, Yushuai; Geng, Yuanyuan; Yue, Beilei; Lo, Pui-Chi; Huang, Jing*; Jin, Honglin*Frontiers in Immunology, 2022, 13: 832942.被引 16
- Injectable Supramolecular Hydrogel for Locoregional Immune Checkpoint Blockade and Enhanced Cancer Chemo-ImmunotherapyLiu, Mengting; Cao, Ziyang; Zhang, Runlin; Chen, Yunhua; Yang, Xianzhu*ACS applied materials & interfaces, 2021, 13(29): 33874-33884.被引 32
- Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogelLi, Xianlei; Gong, Ningqiang*; Tian, Falin; Zhang, Shangkun; Zhang, Yuxuan; Wang, Yufei; Qing, Guangchao; Wang, Yongchao; Li, Fangzhou; Xu, Yihui; Zhang, Linlin; Wang, Jinjin; Ni, Qiankun; Gan, Yaling; Gu, Chaojiang; Jiang, Huaidong; Huang, Xingxu; Shi, Xinghua; Zhang, Tongcun; Wu, Yan*; Liang, Xing-Jie*Nature Biomedical Engineering, 2023, 7(9).被引 5
